Health Canada issued Draft Guidance on 30 March on the Preparation of Drug Regulatory Activities in electronic Common Technical Documents (eCTDs). The guidance, which provides more options for sponsors of submissions, is effective immediately since it does not impose any new obligations. The exception to immediate effect-section 3.4.1 Module 1: Administrative and Product Information-will only be usable when the revised Canadian Module 1 Schema is published and adopted.
Read more: